Plasma levels of active glucagon-like peptide-1 and coronary artery disease

Plasma levels of active glucagon-like peptide-1 and coronary artery disease - Plasma levels of active GLP-1 and CAD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008881

Enrollment

500

Registered

2012-09-12

Start date

2009-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with coronary artery disease at a stable condition and stable patients with more than one conventional coronary risk factors.

Exclusion criteria

Exclusion criteria: severe valvular disease cardiomyopathy significant inflamatory disease neoplasms trauma current use of incretin related drugs unstable condition

Design outcomes

Primary

Measure	Time frame
Correlation between plasma levels of active GLP-1 and coronary artery disease. 1. presence of coronary artery disease 2. endothelial function 3. Composite endopoint of cardiovascular death, non-fatal myocardial infarction, unstable angina pectoris, non-fatal ischemic stroke, re-hospitalization for HF, or coronary revascularization	—

Secondary

Measure	Time frame
SYNTAX score echocardiographic parameters	—

Countries

Japan

Contacts

Public ContactSeigo Sugiyama

Faculty of Life Sciences, Kumamoto University Department of Cardiovascular Medicine

ssugiyam@kumamoto-u.ac.jp81-96-373-5175

Outcome results